{"id":536210,"date":"2021-09-09T08:03:17","date_gmt":"2021-09-09T12:03:17","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\/"},"modified":"2021-09-09T08:03:17","modified_gmt":"2021-09-09T12:03:17","slug":"invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\/","title":{"rendered":"InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference<\/b><\/p>\n<p>CAMBRIDGE, Mass.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<b>InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), <\/b>a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that Richard Toselli, M.D., President and Chief Executive Officer, will present at the upcoming H.C. Wainwright Annual Global Investment Conference, which runs from September 13 \u2013 15, 2021. The conference will be held in a virtual format.\n<\/p>\n<p>\nA webcast of Dr. Toselli\u2019s presentation will be available on the Investor Relations &#8211; Events section of the company website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.invivotherapeutics.com%2Fevents&amp;esheet=52488214&amp;newsitemid=20210909005089&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestors.invivotherapeutics.com%2Fevents&amp;index=1&amp;md5=d984b030a542866d55c9fede01a81e3f\">https:\/\/investors.invivotherapeutics.com\/events<\/a>, beginning September 13, 2021 at 7:00 am ET. Dr. Toselli and company management will also be available to participate in one-on-one meetings with investors who are registered to attend the conference.\n<\/p>\n<p><b>About InVivo Therapeutics<\/b><\/p>\n<p>\nInVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology co-invented by Robert Langer, Sc.D., Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who then was at Boston Children\u2019s Hospital and who now is affiliated with Massachusetts General Hospital. The publicly traded company is headquartered in Cambridge, MA. For more details, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.invivotherapeutics.com&amp;esheet=52488214&amp;newsitemid=20210909005089&amp;lan=en-US&amp;anchor=www.invivotherapeutics.com&amp;index=2&amp;md5=38c9cdcc7ee17a57de4fec8467d4c269\">www.invivotherapeutics.com<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210909005089r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210909005089\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210909005089\/en\/<\/a><\/span><\/p>\n<p><b>Investors:<br \/>\n<\/b><br \/>Bret Shapiro, Managing Partner<br \/>\n<br \/>CORE IR<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:brets@coreir.com\">brets@coreir.com<br \/>\n<\/a><br \/>(516) 222-2560\n<\/p>\n<p><b>Media<br \/>\n<\/b><br \/>Gina Nugent<br \/>\n<br \/>Ten Bridge Communications<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:gina@tenbridgecommunications.com\">gina@tenbridgecommunications.com<br \/>\n<\/a><br \/>617-460-3579\n<\/p>\n<p><b>KEYWORDS:<\/b> United States North America Massachusetts<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Health Science Research Clinical Trials<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210909005089\/en\/833207\/3\/InVivo_logo_RGB.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that Richard Toselli, M.D., President and Chief Executive Officer, will present at the upcoming H.C. Wainwright Annual Global Investment Conference, which runs from September 13 \u2013 15, 2021. The conference will be held in a virtual format. A webcast of Dr. Toselli\u2019s presentation will be available on the Investor Relations &#8211; Events section of the company website at https:\/\/investors.invivotherapeutics.com\/events, beginning September 13, 2021 at 7:00 am ET. Dr. Toselli and company management will also be available to participate in one-on-one &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-536210","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that Richard Toselli, M.D., President and Chief Executive Officer, will present at the upcoming H.C. Wainwright Annual Global Investment Conference, which runs from September 13 \u2013 15, 2021. The conference will be held in a virtual format. A webcast of Dr. Toselli\u2019s presentation will be available on the Investor Relations &#8211; Events section of the company website at https:\/\/investors.invivotherapeutics.com\/events, beginning September 13, 2021 at 7:00 am ET. Dr. Toselli and company management will also be available to participate in one-on-one &hellip; Continue reading &quot;InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-09T12:03:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210909005089r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference\",\"datePublished\":\"2021-09-09T12:03:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\\\/\"},\"wordCount\":282,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210909005089r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\\\/\",\"name\":\"InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210909005089r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-09-09T12:03:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210909005089r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210909005089r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\/","og_locale":"en_US","og_type":"article","og_title":"InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference - Market Newsdesk","og_description":"InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that Richard Toselli, M.D., President and Chief Executive Officer, will present at the upcoming H.C. Wainwright Annual Global Investment Conference, which runs from September 13 \u2013 15, 2021. The conference will be held in a virtual format. A webcast of Dr. Toselli\u2019s presentation will be available on the Investor Relations &#8211; Events section of the company website at https:\/\/investors.invivotherapeutics.com\/events, beginning September 13, 2021 at 7:00 am ET. Dr. Toselli and company management will also be available to participate in one-on-one &hellip; Continue reading \"InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-09T12:03:17+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210909005089r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference","datePublished":"2021-09-09T12:03:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\/"},"wordCount":282,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210909005089r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\/","name":"InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210909005089r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-09-09T12:03:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210909005089r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210909005089r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/invivo-therapeutics-announces-participation-at-upcoming-h-c-wainwright-annual-global-investment-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/536210","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=536210"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/536210\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=536210"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=536210"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=536210"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}